United States Anterior Uveitis Drug Market Report & Forecast 2021-2027

United States Anterior Uveitis Drug Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Anterior Uveitis Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Anterior Uveitis Drug Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Anterior Uveitis Drug Overall Market Size
2.1 United States Anterior Uveitis Drug Market Size: 2021 VS 2027
2.2 United States Anterior Uveitis Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Anterior Uveitis Drug Sales: 2016-2027
3 Company Landscape
3.1 Top Anterior Uveitis Drug Players in United States Market
3.2 Top United States Anterior Uveitis Drug Companies Ranked by Revenue
3.3 United States Anterior Uveitis Drug Revenue by Companies
3.4 United States Anterior Uveitis Drug Sales by Companies
3.5 United States Anterior Uveitis Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Anterior Uveitis Drug Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Anterior Uveitis Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anterior Uveitis Drug Players in United States Market
3.8.1 List of Tier 1 Anterior Uveitis Drug Companies in United States
3.8.2 List of Tier 2 and Tier 3 Anterior Uveitis Drug Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Anterior Uveitis Drug Market Size Markets, 2021 & 2027
4.1.2 Dalazatide
4.1.3 LME-636
4.1.4 NOP-3
4.1.5 Others
4.2 By Type - United States Anterior Uveitis Drug Revenue & Forecasts
4.2.1 By Type - United States Anterior Uveitis Drug Revenue, 2016-2021
4.2.2 By Type - United States Anterior Uveitis Drug Revenue, 2022-2027
4.2.3 By Type - United States Anterior Uveitis Drug Revenue Market Share, 2016-2027
4.3 By Type - United States Anterior Uveitis Drug Sales & Forecasts
4.3.1 By Type - United States Anterior Uveitis Drug Sales, 2016-2021
4.3.2 By Type - United States Anterior Uveitis Drug Sales, 2022-2027
4.3.3 By Type - United States Anterior Uveitis Drug Sales Market Share, 2016-2027
4.4 By Type - United States Anterior Uveitis Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Anterior Uveitis Drug Market Size, 2021 & 2027
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - United States Anterior Uveitis Drug Revenue & Forecasts
5.2.1 By Application - United States Anterior Uveitis Drug Revenue, 2016-2021
5.2.2 By Application - United States Anterior Uveitis Drug Revenue, 2022-2027
5.2.3 By Application - United States Anterior Uveitis Drug Revenue Market Share, 2016-2027
5.3 By Application - United States Anterior Uveitis Drug Sales & Forecasts
5.3.1 By Application - United States Anterior Uveitis Drug Sales, 2016-2021
5.3.2 By Application - United States Anterior Uveitis Drug Sales, 2022-2027
5.3.3 By Application - United States Anterior Uveitis Drug Sales Market Share, 2016-2027
5.4 By Application - United States Anterior Uveitis Drug Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Aciont Inc.
6.1.1 Aciont Inc. Corporation Information
6.1.2 Aciont Inc. Overview
6.1.3 Aciont Inc. Anterior Uveitis Drug Sales and Revenue in United States Market (2016-2021)
6.1.4 Aciont Inc. Anterior Uveitis Drug Product Description
6.1.5 Aciont Inc. Recent Developments
6.2 Aldeyra Therapeutics, Inc.
6.2.1 Aldeyra Therapeutics, Inc. Corporation Information
6.2.2 Aldeyra Therapeutics, Inc. Overview
6.2.3 Aldeyra Therapeutics, Inc. Anterior Uveitis Drug Sales and Revenue in United States Market (2016-2021)
6.2.4 Aldeyra Therapeutics, Inc. Anterior Uveitis Drug Product Description
6.2.5 Aldeyra Therapeutics, Inc. Recent Developments
6.3 EyeGate Pharmaceuticals, Inc.
6.3.1 EyeGate Pharmaceuticals, Inc. Corporation Information
6.3.2 EyeGate Pharmaceuticals, Inc. Overview
6.3.3 EyeGate Pharmaceuticals, Inc. Anterior Uveitis Drug Sales and Revenue in United States Market (2016-2021)
6.3.4 EyeGate Pharmaceuticals, Inc. Anterior Uveitis Drug Product Description
6.3.5 EyeGate Pharmaceuticals, Inc. Recent Developments
6.4 KPI Therapeutics, Inc.
6.4.1 KPI Therapeutics, Inc. Corporation Information
6.4.2 KPI Therapeutics, Inc. Overview
6.4.3 KPI Therapeutics, Inc. Anterior Uveitis Drug Sales and Revenue in United States Market (2016-2021)
6.4.4 KPI Therapeutics, Inc. Anterior Uveitis Drug Product Description
6.4.5 KPI Therapeutics, Inc. Recent Developments
6.5 Neuroptis Biotech
6.5.1 Neuroptis Biotech Corporation Information
6.5.2 Neuroptis Biotech Overview
6.5.3 Neuroptis Biotech Anterior Uveitis Drug Sales and Revenue in United States Market (2016-2021)
6.5.4 Neuroptis Biotech Anterior Uveitis Drug Product Description
6.5.5 Neuroptis Biotech Recent Developments
7 United States Anterior Uveitis Drug Production Capacity, Analysis
7.1 United States Anterior Uveitis Drug Production Capacity, 2016-2027
7.2 Anterior Uveitis Drug Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Anterior Uveitis Drug Supply Chain Analysis
9.1 Anterior Uveitis Drug Industry Value Chain
9.2 Anterior Uveitis Drug Upstream Market
9.3 Anterior Uveitis Drug Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Anterior Uveitis Drug Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Anterior Uveitis Drug in United States Market
Table 2. Top Anterior Uveitis Drug Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Anterior Uveitis Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Anterior Uveitis Drug Revenue Share by Companies, 2016-2021
Table 5. United States Anterior Uveitis Drug Sales by Companies, (K Pcs), 2016-2021
Table 6. United States Anterior Uveitis Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Anterior Uveitis Drug Price (2016-2021) & (USD/Pcs)
Table 8. Manufacturers Anterior Uveitis Drug Product Type
Table 9. List of Tier 1 Anterior Uveitis Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Anterior Uveitis Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Dalazatide
Table 12. Major Manufacturers of LME-636
Table 13. By Type - United States Anterior Uveitis Drug Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Anterior Uveitis Drug Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Anterior Uveitis Drug Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Anterior Uveitis Drug Sales (K Pcs), 2016-2021
Table 17. By Type - United States Anterior Uveitis Drug Sales (K Pcs), 2022-2027
Table 18. By Application - United States Anterior Uveitis Drug Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Anterior Uveitis Drug Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Anterior Uveitis Drug Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Anterior Uveitis Drug Sales (K Pcs), 2016-2021
Table 22. By Application - United States Anterior Uveitis Drug Sales (K Pcs), 2022-2027
Table 23. Aciont Inc. Corporation Information
Table 24. Aciont Inc. Description and Major Businesses
Table 25. Aciont Inc. Anterior Uveitis Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 26. Aciont Inc. Anterior Uveitis Drug Product
Table 27. Aciont Inc. Recent Developments
Table 28. Aldeyra Therapeutics, Inc. Corporation Information
Table 29. Aldeyra Therapeutics, Inc. Description and Major Businesses
Table 30. Aldeyra Therapeutics, Inc. Anterior Uveitis Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 31. Aldeyra Therapeutics, Inc. Anterior Uveitis Drug Product
Table 32. Aldeyra Therapeutics, Inc. Recent Developments
Table 33. EyeGate Pharmaceuticals, Inc. Corporation Information
Table 34. EyeGate Pharmaceuticals, Inc. Description and Major Businesses
Table 35. EyeGate Pharmaceuticals, Inc. Anterior Uveitis Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 36. EyeGate Pharmaceuticals, Inc. Anterior Uveitis Drug Product
Table 37. EyeGate Pharmaceuticals, Inc. Recent Developments
Table 38. KPI Therapeutics, Inc. Corporation Information
Table 39. KPI Therapeutics, Inc. Description and Major Businesses
Table 40. KPI Therapeutics, Inc. Anterior Uveitis Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 41. KPI Therapeutics, Inc. Anterior Uveitis Drug Product
Table 42. KPI Therapeutics, Inc. Recent Developments
Table 43. Neuroptis Biotech Corporation Information
Table 44. Neuroptis Biotech Description and Major Businesses
Table 45. Neuroptis Biotech Anterior Uveitis Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 46. Neuroptis Biotech Anterior Uveitis Drug Product
Table 47. Neuroptis Biotech Recent Developments
Table 48. Anterior Uveitis Drug Production Capacity (K Pcs) of Key Manufacturers in United States Market, 2019-2021 (K Pcs)
Table 49. United States Anterior Uveitis Drug Capacity Market Share of Key Manufacturers, 2019-2021
Table 50. Anterior Uveitis Drug Market Opportunities & Trends in United States Market
Table 51. Anterior Uveitis Drug Market Drivers in United States Market
Table 52. Anterior Uveitis Drug Market Restraints in United States Market
Table 53. Anterior Uveitis Drug Raw Materials
Table 54. Anterior Uveitis Drug Raw Materials Suppliers in United States Market
Table 55. Typical Anterior Uveitis Drug Downstream
Table 56. Anterior Uveitis Drug Downstream Clients in United States Market
Table 57. Anterior Uveitis Drug Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Anterior Uveitis Drug Product Picture
Figure 2. Anterior Uveitis Drug Segment by Type
Figure 3. Anterior Uveitis Drug Segment by Application
Figure 4. United States Anterior Uveitis Drug Market Overview: 2020
Figure 5. United States Anterior Uveitis Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Anterior Uveitis Drug Revenue, 2016-2027 (US$, Mn)
Figure 7. Anterior Uveitis Drug Sales in United States Market: 2016-2027 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Anterior Uveitis Drug Revenue in 2020
Figure 9. Dalazatide Product Picture
Figure 10. LME-636 Product Picture
Figure 11. NOP-3 Product Picture
Figure 12. Others Product Picture
Figure 13. By Type - United States Anterior Uveitis Drug Sales Market Share, 2016-2027
Figure 14. By Type - United States Anterior Uveitis Drug Revenue Market Share, 2016-2027
Figure 15. By Type - United States Anterior Uveitis Drug Price (USD/Pcs), 2016-2027
Figure 16. Clinic
Figure 17. Hospital
Figure 18. Others
Figure 19. By Application - United States Anterior Uveitis Drug Sales Market Share, 2016-2027
Figure 20. By Application - United States Anterior Uveitis Drug Revenue Market Share, 2016-2027
Figure 21. By Application - United States Anterior Uveitis Drug Price (USD/Pcs), 2016-2027
Figure 22. Aciont Inc. Anterior Uveitis Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Aldeyra Therapeutics, Inc. Anterior Uveitis Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. EyeGate Pharmaceuticals, Inc. Anterior Uveitis Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. KPI Therapeutics, Inc. Anterior Uveitis Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Neuroptis Biotech Anterior Uveitis Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. United States Anterior Uveitis Drug Production Capacity (K Pcs), 2016-2027
Figure 28. Anterior Uveitis Drug Industry Value Chain
Figure 29. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs